Test Price
2,800 AED✅ Home Collection Available
MEOX1 Gene Klippel-Feil Syndrome Type 2 Autosomal Dominant Genetic Test — 2,800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytical sensitivity via ISO-certified targeted NGS with Sanger confirmation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection — available daily from 8 AM to 11 PM.
- Clinical Guidance: Post-test genetic counseling phone consultation with our specialist medical genetics team.
- Insurance Verification: Direct coverage check via WhatsApp at +971 54 548 8731.
- Turnaround Time: 3–4 Weeks from sample receipt.
Test Overview & Methodology
The MEOX1 Gene Klippel-Feil Syndrome Type 2 Genetic Test employs targeted next-generation sequencing to detect pathogenic variants in the MEOX1 gene, confirming the autosomal dominant form of Klippel-Feil syndrome characterized by congenital fusion of cervical vertebrae. This molecular assay is indicated for early clinical diagnosis, familial cascade screening, genetic counseling, and informed reproductive planning.
| Feature | Our Test (MEOX1 NGS) | Closest Alternative (Multi-gene Panel NGS) |
|---|---|---|
| Precision | Single-gene high-depth coverage >99.5% analytical sensitivity | Moderate coverage across multiple genes; may miss intronic variants |
| Methodology | Targeted NGS with Sanger confirmation | Whole-exome or large gene panel NGS |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price | 2,800 AED | 3,500–5,000 AED (est.) |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I recognize that definitive molecular diagnosis of Klippel-Feil syndrome type 2 through MEOX1 sequencing provides critical guidance for orthopedic surveillance and family counseling. However, all genetic results must be interpreted alongside clinical and radiographic findings and a detailed three-generation pedigree. Patients should not alter their management plan without consulting their specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication and Treatment Advisory
Do not discontinue any prescribed medication, orthopedic brace, or physical therapy regimen without consulting your treating physician or specialist.
Exclusion Criteria & Emergency Red Flags
- Inadequate sample (hemolyzed blood, insufficient DNA yield) — recollection will be requested.
- Individuals under 18 years without a legal guardian's informed consent, in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Patients with active bleeding disorders or those unable to undergo venipuncture.
- ER Red Flags: Sudden severe neck pain, new-onset limb weakness or numbness, or difficulty breathing — these may indicate spinal instability requiring urgent evaluation and are not related to the blood draw procedure.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of MEOX1 gene testing for Klippel-Feil syndrome?
The MEOX1 NGS test definitively confirms type 2 Klippel-Feil syndrome by identifying pathogenic variants in the MEOX1 gene. This guides orthopedic management, surveillance protocols, and enables precise familial risk assessment for informed reproductive planning.
2. How should I prepare for sample collection and what does the procedure involve?
No fasting or special preparation is required. A trained phlebotomist will collect a peripheral whole blood sample during a VIP home visit. The specimen is transported via an ISO-certified temperature-controlled cold chain to the laboratory, where DNA is extracted and sequenced using targeted NGS with Sanger confirmation.
3. Are my genetic data and privacy protected under UAE law?
Yes. All genetic data are handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results are shared only with your authorized physician and yourself, under strict confidentiality protocols and encrypted data storage.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — full encryption and data storage compliance.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — health data cybersecurity and handling standards.
- Federal Decree-Law No. 4 of 2016 on Medical Liability — patient consent, clinical safety, and professional accountability.
- DHA Facility License No. 1143; ISO 9001:2015 certified quality management system.
- Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE.
- Home collection service available daily 8 AM to 11 PM; WhatsApp support: +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | MEOX1 Gene Klippel-Feil Syndrome Type 2 Autosomal Dominant Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Targeted NGS with Sanger Confirmation |
| ICD-10-CM Code | Q74.0 |
| LOINC Code | 81411-9 |
| DHA Facility License & Laboratory Address Invariants | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians